<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: AZN News</title><copyright>Copyright (c) 2013 Yahoo! Southeast Asia Pte Ltd. (Co. Reg. No. 199700735D) All rights reserved.</copyright><link>http://sg.finance.yahoo.com/q/h?s=azn</link><description>Latest Financial News for Astrazeneca PLC Common Stock</description><language>en-SG</language><lastBuildDate>Wed, 19 Jun 2013 23:08:29 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Finance: AZN News</title><link>http://sg.finance.yahoo.com/q/h?s=azn</link><width>144</width><height>45</height></image><item><title>Will Amarin&apos;s Fish Oil Drug Slip Past the FDA a Second Time?</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13a8phi7k/*http://www.fool.com/investing/general/2013/06/19/will-amarins-fish-oil-drug-slip-past-the-fda-a-sec.aspx?source=eogyholnk0000001</link><description></description><guid isPermaLink="false">yahoo_finance/2803477951</guid><pubDate>Wed, 19 Jun 2013 23:08:29 GMT</pubDate></item><item><title>3 Drug Stocks Poised To Move As Bears Attack</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12tkppvsu/*http://www.thestreet.com/story/11955666/1/3-drug-stocks-poised-to-move-as-bears-attack.html?puc=yahoo&amp;cm_ven=YAHOO</link><description></description><guid isPermaLink="false">yahoo_finance/4028085019</guid><pubDate>Wed, 19 Jun 2013 21:26:00 GMT</pubDate></item><item><title>Wal-Mart’s Online Battle, AstraZeneca Diabetes Drug Falls Through, and 3 More Hot Stocks</title><link>http://us.rd.yahoo.com/finance/external/xwscheats/rss/SIG=140mkedps/*http://wallstcheatsheet.com/stocks/wal-marts-online-battle-astrazeneca-diabetes-drug-falls-through-and-3-more-hot-stocks.html/?ref=YF</link><description></description><guid isPermaLink="false">yahoo_finance/2268793457</guid><pubDate>Wed, 19 Jun 2013 17:41:07 GMT</pubDate></item><item><title>Top Line Results: No Cardiovascular Benefits Found For Saxagliptin</title><link>http://us.rd.yahoo.com/finance/external/forbes/rss/SIG=13n8ph31g/*http://www.forbes.com/sites/larryhusten/2013/06/19/top-line-results-no-cardiovascular-benefits-found-for-saxagliptin/?partner=yahootix</link><description></description><guid isPermaLink="false">yahoo_finance/3739230430</guid><pubDate>Wed, 19 Jun 2013 17:27:00 GMT</pubDate></item><item><title>An AstraZeneca And Bristol-Myers Diabetes Trial Is A Dud</title><link>http://us.rd.yahoo.com/finance/external/forbes/rss/SIG=13edpv2n3/*http://www.forbes.com/sites/edsilverman/2013/06/19/an-astrazeneca-and-bristol-myers-diabetes-trial-is-a-dud/?partner=yahootix</link><description></description><guid isPermaLink="false">yahoo_finance/221990336</guid><pubDate>Wed, 19 Jun 2013 17:25:00 GMT</pubDate></item><item><title>Astra, Bristol diabetes drug disappoints in key test</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/astrazeneca-bristol-diabetes-drug-disappoints-065504442.html</link><description></description><guid isPermaLink="false">yahoo_finance/371857374</guid><pubDate>Wed, 19 Jun 2013 16:09:02 GMT</pubDate></item><item><title>Amarin: FDA Panel Date, Misplaced Hype For Fixed-Dose Combo</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13aqocd0f/*http://www.thestreet.com/story/11955060/1/amarin-fda-panel-date-misplaced-hype-for-fixed-dose-combo.html?puc=yahoo&amp;cm_ven=YAHOO</link><description></description><guid isPermaLink="false">yahoo_finance/3281470786</guid><pubDate>Wed, 19 Jun 2013 15:22:00 GMT</pubDate></item><item><title>Study: no new benefits for diabetes drug Onglyza</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/study-no-benefits-diabetes-drug-151601564--finance.html</link><description></description><guid isPermaLink="false">yahoo_finance/1859186643</guid><pubDate>Wed, 19 Jun 2013 15:16:01 GMT</pubDate></item><item><title>Study: no new benefits for diabetes drug Onglyza</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/study-no-benefits-diabetes-drug-151601536.html</link><description></description><guid isPermaLink="false">yahoo_finance/3305206186</guid><pubDate>Wed, 19 Jun 2013 15:16:01 GMT</pubDate></item><item><title>Early Movers: FDX, ADBE DELL, BA, BBRY &amp; More</title><link>http://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=112dgqmi6/*http://www.cnbc.com/id/100827402?__source=yahoo|finance|headline|headline|story&amp;par=yahoo&amp;doc=100827402|Early+Movers:+FDX,+ADBE+D</link><description></description><guid isPermaLink="false">yahoo_finance/3427636477</guid><pubDate>Wed, 19 Jun 2013 11:45:09 GMT</pubDate></item><item><title>AstraZeneca, Bristol diabetes drug fails to show heart benefit</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/astrazeneca-bristol-diabetes-drug-fails-061521360.html</link><description></description><guid isPermaLink="false">yahoo_finance/431931495</guid><pubDate>Wed, 19 Jun 2013 06:15:21 GMT</pubDate></item><item><title>AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza® (saxagliptin)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/astrazeneca-bristol-myers-squibb-announce-060200179.html</link><description>[Business Wire] - Bristol-Myers Squibb Company and AstraZeneca today announced top line results of the Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza ® .</description><guid isPermaLink="false">yahoo_finance/4192679759</guid><pubDate>Wed, 19 Jun 2013 06:02:00 GMT</pubDate></item><item><title>AstraZeneca and NGM Collaborate</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/astrazeneca-ngm-collaborate-202002178.html</link><description></description><guid isPermaLink="false">yahoo_finance/2820210486</guid><pubDate>Tue, 18 Jun 2013 20:20:02 GMT</pubDate></item><item><title>AstraZeneca turnaround is 3-4 year journey, says CEO</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/astrazeneca-turnaround-3-4-journey-164643187.html</link><description></description><guid isPermaLink="false">yahoo_finance/2468767501</guid><pubDate>Tue, 18 Jun 2013 16:46:43 GMT</pubDate></item><item><title>Dividend Challengers: 17 Increases Expected By August 30</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13147n28o/*http://seekingalpha.com/article/1508302-dividend-challengers-17-increases-expected-by-august-30?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/585231118</guid><pubDate>Tue, 18 Jun 2013 16:33:11 GMT</pubDate></item><item><title>Top Treatments for High Cholesterol</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12rofche0/*http://www.fool.com/investing/general/2013/06/17/top-treatments-for-high-cholesterol.aspx?source=eogyholnk0000001</link><description></description><guid isPermaLink="false">yahoo_finance/3972364709</guid><pubDate>Tue, 18 Jun 2013 16:26:48 GMT</pubDate></item><item><title>AstraZeneca turnaround is 3-4 year journey - CEO</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/astrazeneca-turnaround-3-4-journey-161822207.html</link><description></description><guid isPermaLink="false">yahoo_finance/2150536946</guid><pubDate>Tue, 18 Jun 2013 16:18:22 GMT</pubDate></item><item><title>AstraZeneca turnaround is 3-4 year journey, says CEO</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/astrazeneca-turnaround-3-4-journey-161630862.html</link><description></description><guid isPermaLink="false">yahoo_finance/2290659518</guid><pubDate>Tue, 18 Jun 2013 16:16:30 GMT</pubDate></item><item><title>The NIH Aims To Develop Drugs That Big Pharma Discarded</title><link>http://us.rd.yahoo.com/finance/external/forbes/rss/SIG=13fcfgbto/*http://www.forbes.com/sites/matthewherper/2013/06/18/the-nih-aims-to-develop-drugs-that-big-pharma-discarded/?partner=yahootix</link><description></description><guid isPermaLink="false">yahoo_finance/3698923417</guid><pubDate>Tue, 18 Jun 2013 16:16:00 GMT</pubDate></item><item><title>Teva to Acquire MicroDose Therapeutx</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/teva-acquire-microdose-therapeutx-150003781.html</link><description></description><guid isPermaLink="false">yahoo_finance/472753786</guid><pubDate>Tue, 18 Jun 2013 15:00:03 GMT</pubDate></item></channel></rss>